These 5 trends are shaping the UK biopharma investment landscape
The UK needs to move away from having lots of early-stage biotech companies towards supporting the development of firms through to later-stage.
VC report: Healthcare IPO and M&A strong, but devices and diagnostics massively outpaced by biopharma
When it comes to investment, M&A and IPO, devices and diagnostics remain a tad neglected – and biopharma the star – though 2014 was a boom year for healthcare and 2015 keeps going strong. Silicon Valley Bank just put out a report on that M&A and IPO activity, populated with some interesting facts and figures that contrast the […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
presented by
Venture Capital: The medtech/biotech playing field’s askew, and other healthcare trends
Medical device companies are having a much harder time raising early-stage venture capital than biotech and pharma, according to a recent Silicon Valley Bank report. “On the Series A side of things, biotech is a pretty stable area right now, but devices have some significant issues in trying to find ventures to support Series A company creation,” […]
When should you take on venture debt? When you don’t need the money
Debt isn’t always a dirty word in the world of startups. Yesterday I heard John Hoesley from Silicon Valley Bank give a brief presentation on venture debt as a funding mechanism for startups at a capital connections event hosted by BioOhio. He mentioned that SVB has seen an uptick in its venture debt business over […]
Study: Medical device startups optimistic despite expected hit from tax
A new Silicon Valley Bank report on the medical device tax has more bright spots than you would expect. Executives from device companies seem to feel optimistic, even though they expect the tax to delay profitability.